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1875-9572/Copyright ª 2015, TaiwanBackground: Neonatal hypoxic ischemic encephalopathy (HIE) is a major cause of mortality,
morbidity, and long-term neurological deficits. Despite the availability of neuroimaging and
neurophysiological testing, tools for accurate early diagnosis and prediction of developmental
outcome are still lacking. The goal of this study was to determine if combined use of magnetic
resonance imaging (MRI) and electroencephalography (EEG) findings could support outcome
prediction.
Methods: We retrospectively reviewed records of 17 HIE neonates, classified brain MRI and EEG
findings based on severity, and assessed clinical outcome up to 48 months. We determined the
relation between MRI/EEG findings and clinical outcome.
Results: We demonstrated a significant relationship between MRI findings and clinical outcome
(Fisher’s exact test, p Z 0.017). EEG provided no additional information about the outcome
beyond that contained in the MRI score. The statistical model for outcome prediction based
on random forests suggested that EEG readings at 24 hours and 72 hours could be important
variables for outcome prediction, but this needs to be investigated further.
Conclusion: Caution should be used when discussing prognosis for neonates with mild-to-
moderate HIE based on early MR imaging and EEG findings. A robust, quantitative marker of
HIE severity that allows for accurate prediction of long-term outcome, particularly for mild-
to-moderate cases, is still needed.
Copyright ª 2015, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.of Pediatrics, PO Box 9214 Morgantown, WV 26506-9214, USA.
.edu (P. Pergami).
014.12.005
Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.
308 T. Nanavati et al1. IntroductionNeonatal hypoxic ischemic encephalopathy (HIE) occurs in
1e2/1000 live births, accounts for 23% of neonatal deaths,
and is the fifth largest cause of death in children under 5
years.1
Brain hypoxia triggers a cascade of events leading to
neuronal death 12e36 hours after the initial ischemic
insult,2 so prompt recognition is imperative for early,
effective interventions that will prevent loss of neurons,
including therapeutic hypothermia.3 In addition, identifi-
cation of HIE and accurate classification of severity are
important for reliable prediction of clinical outcome and
long-term planning. Routine diagnostic modalities including
electroencephalography (EEG) and magnetic resonance
imaging (MRI) are somewhat limited tools, particularly in
cases of moderate severity.
We investigated the relationship between EEG and MRI
findings and outcome in infants with HIE who underwent
therapeutic hypothermia. As a secondary investigation, we
considered the predictive utility of EEG and MRI findings at
24 hours and 72 hours for determining the clinical outcome.
2. Methods
This study was approved by the West Virginia University
Institutional Review Board (Morgantown, WV, USA). All
newborns with HIE who underwent therapeutic hypother-
mia (total body cooling) at West Virginia University Hospital
(WVUH) between 2009 and 2013 were included in this
retrospective study. Clinical data were obtained from
electronic medical records (Table 1).
2.1. Cooling protocol
The decision to cool infants was based on inclusion/exclu-
sion criteria as published (Appendix 1).4 Cooling was ach-
ieved by a cooling blanket to an esophageal temperature of
33.5C for 72 hours, followed by slow rewarming by 0.5C/h.
2.2. Neurodevelopmental outcome
Outcome was monitored at 6 months, 12 months, 24
months, or 36 months by neurologic examination, Denver
developmental scales (DDST).7 Pediatric Stroke Outcome
Measure (PSOM)9 and, when possible, Bayley Scales of In-
fant Development (BSID).8 All evaluations were performed
by a certified pediatric neurologist, or by neuro-
developmental specialists as part of routine clinical as-
sessments for patients followed in the high-risk neonatal
clinic at WVU. Most recent assessments are reported for
each individual (Table 2). All neurological evaluations
were assigned a numeric value of progressive severity
(Table 3). DDST scores were as follows: 1, normal; 2, mild
delay; 3, moderate delay; and 4, severe delay for each
category (personal/social, language, fine motor/adaptive,
gross motor). PSOM scale includes sensorimotor, language,
and cognitive/behavioral evaluation with a maximum total
score of 10. BSID includes scoring for motor developmentindex (MDI) and psychomotor development index (PDI)
with 1e4 scoring levels of progressive severity. The above
scores were averaged in a Global Outcome Score (Tables 2
and 3). All assessments were performed by a certified
pediatric neurologist and/or by a child development
specialist.
2.3. MRI
Brain MRI (1.5 or 3 Tesla) was obtained within 1 week after
birth including T1-and T2-weighted images, Fluid Attenu-
ated Inversion Recovery(FLAIR), diffusion weighted imaging
(DWI), and apparent diffusion coefficient (ADC) sequences.
Contrast was used in all patients (0.8 mL Magnevist, Bayer,
Toronto, Ontario, Canada). MRI images were evaluated by
board-certified neuroradiologists and classified into three
groups: 1 Z normal; 2 Z mild restricted diffusion in
cortical gray matter or deep nuclei; and 3 Z severe
restricted diffusion with or without cystic encephalomala-
cia. This classification was based on a previously published
scoring method,10 but given the small number of partici-
pants in this report, mild and moderate MRI abnormalities
were merged as level 2.
2.4. EEG findings
Continuous electroencephalogram monitoring was obtained
for 72 hours. Findings were evaluated by a board-certified
epileptologist and classified at 24 hours and 72 hours into
four groups of increasing severity: 1 Z normal; 2 Z rare
spikes and/or sharp waves; 3 Z moderate slowing with or
without epileptiform discharges; and 4 Z low voltage or
severe suppression, with or without prolonged or multiple
seizures. Seizures were defined as electrographic seizures
detected on EEG according to the definition of Classen and
co-workers5 of “rhythmic discharge or spike and wave
pattern with definite evolution in frequency, location, or
morphology lasting at least 10 sec”. Electrographic defini-
tion of seizures was deemed necessary as it has been re-
ported that only one-third of neonatal EEG seizures displays
clinical signs on simultaneous video recordings.5,6
2.5. Statistical analysis
Positive and negative predictive values, sensitivity, and
specificity were calculated for EEG and MRI findings and
clinical outcome; positive or negative test and normal/
abnormal outcome were used for these calculations,
without characterization of levels of severity.
We used Spearman’s rank correlation (rs) for a
nonparametric assessment of the association between MRI
and EEG on day of life (DOL) 1 (24 hours), and DOL 3 (72
hours). Fisher’s exact test was used to assess the relation-
ship between MRI and EEG with the clinical outcome
(normal, mild delay, moderate delay, and deceased).
Multinomial logistic regression and log-linear regression
were used to assess the combined association of MRI and
EEG with the clinical outcome.
We explored the predictive ability of EEG and MRI scales
using random forests. We performed data preprocessing11
Table 1 Summary of clinical data.
Pt Sex GA (wk) Maternal history (age) Delivery Complications at delivery HIE
severity*
Birth
Wt (g)
APGAR
0 min, 5 min,
10 min
ABG
pH
Postnatal support Sz AED or
sedative
1 F 38 (35) SVD Shoulder dystocia Moderate 3800 0,0,2 6.97* Ventilator and pressors Y Y
2 M 37 (23) anemia SVD Meconium aspiration Moderate 3033 2,4,7 6.98 Ventilator Y Y
3 F 41 (34) SVD Meconium aspiration Moderate 3500 3,7 6.94 Ventilator and pressors N N
4 F 39 (36) SVD DIC, PPHN, ARF Moderate 3000 6,8 6.8 Ventilator and pressors N Y
5 F 38 (17) SVD Abnormal fetal HR Severe 3000 0, 0, 0 7.39 Ventilator and pressors Y N
6 M 40 (29) tobacco ECS Fetal deceleration.
Meconium aspiration
Moderate 3300 3, 7, 8 7.04 Ventilator N Y
7 F 38 DM, preeclampsia
hypothyroidism, (27)
ECS Fetal decelerations Severe 4180 1, 4, 8 6.8 Ventilator N Y
8 F 37 tobacco (18) SVD Fetal decelerations Moderate 2520 1, 1, 4 7.25 Ventilator Y Y
9 M 36 HELLP, polyhydramnios,
tobacco, (30)
CS Hyaline membrane disease, RDS Moderate 3500 1, 2, 6 6.84 Ventilator and pressors N N
10 M 39 (34) ECS Fetal decelerations cord prolapse Moderate 4325 0, 3, 6 7.07 Nasal oxygen Y N
11 M 37 (20) ECS Poor BPP, fetal decelerations Moderate 3033 0, 0, 3 7.39 Ventilator and pressors Y N
12 M 38 (18) SVD Abnormal HR, cord encirclement Severe 2466 1, 1, 2 7.08 Ventilator and pressors Y Y
13 F 41 (28) ECS Fetal decelerations, cord prolapse Severe 3790 0, 0, 5 6.96* Pressors Y Y
14 F 40þ (40) SVD Cord wrapped around body Moderate 3250 2, 4, 6 7.32 Ventilator N N
15 M 36 (18) SVD Delivered at local restaurant Severe 3500 0, 0 7.45 Ventilator and pressors Y Y
16 M 36 DM, HTN, (28) SVD Fetal decelerations Severe 3200 1, 4, 4 7.24 Pressors Y Y
17 M 36 TBI, (31) ECS Fetal decelerations Severe 2500 2, 3, 3 7.29 Ventilator and pressors Y Y
ABG Z arterial blood gas; AED Z antiepileptic drugs; BPP Z biophysical profile; BWt Z birth weight; CS Z Cesarean section; DIC Z disseminated intravascular coagulation;
ECS Z emergency Cesarean section; F Z female; GA Z gestational age; HELLP Z hemolysis elevated liver enzymes low platelet count; HR Z heart rate; M Z male; N Z no;
PPHN Z persistent pulmonary hypertension of the newborn; DM Z Diabetes Mellitus; ARF Z Acute Renal Failure; HTN Z Hypertension; HIE Z Hypoxic Ischemic Encephalopathy;
Pt Z patient; SVD Z standard vaginal delivery; SZ Z seizures; TBI Z traumatic brain injury; UC Z umbilical cord; wk Z weeks; Y Z yes.
* Umbilical cord pH.
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Table 2 Summary of electroencephalography (EEG), magnetic resonance imaging (MRI) findings, and clinical outcome.*
,y,z
Pt EEG findings MRI findings Age of clinical
evaluations (mo)
Neurological
exam score
DDST
Score*
PSOM
scorey
Global
outcome
score
1 DOL 1e2: Low amplitude,
seizures, rare spikes
DOL 4e12: Rare SW
DOL 4: Bilateral restricted
diffusion in parietal/occipital/
temporal WM and thalami
4 1 1 0 1
2 DOL 1e3: Bilateral
epileptiform spikes;
seizures
DOL 4: R PCA stroke 2 1 1 0 1
3 DOL 1e4: Normal DOL 5: No restricted diffusion
or HIE findings
24 1 1 0 1
4 DOL 1e3: Suppressed
DOL 4e5: Normal
DOL 11: No HIE findings 13 1 1 0 1
5 Deceased Deceased 5 5 4 Deceased 4
6 DOL 1: Spikes; diffuse
slowing
DOL 2e5: Diffuse slowing on
R
DOL 28: No HIE findings 14 1 1 0 1
7 DOL 1e5: Severe
suppression
DOL 3: Occipital cystic
encephalomalacia
12,14 4,5 4 2 4
8 DOL 1: Seizures. DOL 2:
Burst suppression; spikes
DOL 3e4: Intermittent SW,
background slowing
DOL 3: No HIE findings 12 1 1 0 1
9 DOL 2e4: Very low voltage No MRI Deceased 5 4 2 4
10 DOL 1:Minimal background
slowing
DOL 2: Normal
DOL 5: Increased T1 signal in
putamen and GP
6 months: Normal
6, 19 1,2 2 0.5 2
11x DOL 1: Rare spikes; mild
suppression
DOL 2e3: Spikes;
discontinuous
DOL 10: Restricted diffusion in
bilateral thalami, corona
radiata and parietal/occipital
cortex
4,36 2,3 3 3.5 3
12 DOL 1e5: Severe
suppression, no reactivity
DOL 5: Restricted diffusion in
bilateral thalami
Deceased 5 4 Deceased 4
13 DOL 1e3: Severe
suppression
No MRI Deceased 5 4 Deceased 4
14x DOL 1e5: Dysmature,
asynchronous
Normal 12 1 1 0 1
15 DOL 1: Multiple seizures
DOL 2e4: Multifocal SW,
asynchrony
DOL 5: Prolonged seizures
Profound HIE in deep gray
matter and corpus callosum.
Relative sparing of cortex
6 5 4 Deceased 4
16 DOL 1e2: Low voltage
background
DOL 3e4: Low voltage rare
spikes
DOL 5: Mild restriction diffusion
in bilateral posterior frontal
and corona radiata
Too young d d d d
17x DOL 1: Bilateral spikes
DOL 2e3: Rare spikes, no
seizures
Moderate HIE with increased
signal in BG, thalami and IC.
Restricted diffusion in
periventricular region
12 2 2 1.5 2
bgZ background; BGZ basal ganglia; DOLZ day of life; GPZ globus pallidus; HIEZ hypoxic ischemic encephalopathy; ICZ internal
capsule; L Z left; PCA Z posterior cerebral artery; Pt Z patient; R Z right; SW Z sharp-waves; WM Z white matter.
jj Denotes that these patients had Bayley Scales of Infant Development (BSID) assessmentce.8
* Denver Developmental Screening Test Development Scale (DDST)7: 1 Z normal; 2 Z mild abnormality (2 cautions and 1 delay);
3 Z moderate (3 cautions and/or 2 delays); and 4 Z severe (4 cautions and/or  3 delays).
y Pediatric Stoke Outcome Measure (PSOM)9: 0 Z no delay; 0.5 Z mild delay; 1 Z moderate delay; 2 Z severe or profound delay.
z Neurological Exam: 1 Z normal; 2 Z mild delay, but function is unaffected; 3 Z moderate delay, function is somewhat affected;
4Z severe delay (spasticity, stiffness, barely functional); and 5Z deceased global outcome score is a combined numeric value of DDST,
PSOM and Neurological exam.
x Criteria per Shankaran et al.4
310 T. Nanavati et al
Table 3 Relationship between electroencephalography
(EEG), magnetic resonance imaging (MRI), and clinical
outcome.*
Patient EEG findings
(24 h)y
EEG findings
(72 h)y
MRI
findingsz
Global
Outcome
Scorex
1 4 3 2 1
2 2 2 Stroke 1
3 1 1 1 1
4 4 1 1 1
5 No EEG No EEG No MRI 4
6 2 to 3 4 1 1
7 4 4 3 4
8 4 2 1 1
9 4 1 No MRI 4
10 2 2 2 2
11 2 2 3 3
12 4 4 3 4
13 4 4 No MRI 4
14 1 1 1 1
15 4 3 3 4
16 4 3 2 Too young
17 3 3 2 2
* Patients in italics were not used for statistics due to immi-
nent death.
y EEG was classified as: 1 Z normal; 2 Z rare spikes and/or
sharp waves; 3 Z moderate slowing with or without epilepti-
form discharges; and 4 Z low voltage or severe suppression,
with or without prolonged or multiple seizures.
z MRI images were evaluated by board-certified neuroradiol-
ogists and classified into three groups: 1 Z normal; 2 Z mild
restricted diffusion in cortical gray matter or deep nuclei; and
3 Z severe restricted diffusion with or without cystic ence-
phalomalacia. This classification was based on a previously
published scoring method.10
x The Global Outcome Score is a combined numeric score of
the Denver Development Screen (DDST), Pediatric Stroke
Outcome Measure (PSOM), and neurological examination. The
Global Outcome Score is as follows: 1 Z normal; 2 Z mild
delay, 3 Z moderate/severe delay; and 4 Z deceased.
EEG, MRI, and clinical outcome in neonates with HIE 311and near zero predictors. Variables with sparse or unbal-
anced (skewed) distributions were removed, as they
contain insufficient information for stable model con-
struction and may cause the algorithms to fail.12,13 Random
forests of classification trees in conjunction with Scree
plots11 of the variable-importance measure were used to
identify variables that could be important for predicting
the clinical outcome. R statistical software was used for all
analyses.11
3. Results
A total of 17 infants (8 females, 9 males) were identified.
Patients’ clinical details including presence or absence of
seizures are summarized in Table 1. Fifty-eight percent of
patients had moderate HIE, and 41% had severe HIE. A total
of 65% received one or more antiepileptic drugs (AED), and
53% needed pressors. One patient was found to have acute
ischemic stroke and was excluded from all analyses.3.1. Clinical outcome
For the majority of patients, the most recent follow-up visit
was at age 1 year or 2 years. One patient was last evaluated
at 6 months. Seven patients had no delay, six patients were
deceased, and three patients had mild delay. DDST was
obtained in 10 patients, PSOM in 12 patients, and BSID in
three patients (Table 2).
3.2. MRI (n Z 14)
On MRI, six patients had no evidence of brain injury
(score Z 1), four patients had mild restricted diffusion in
cortical or deep nuclei (score Z 2), and three patients had
severe restricted diffusion with or without cystic encephalo-
malacia (scoreZ 3). Three patients died prior toMRI (Tables 2
and 3).
3.3. EEG findings (n Z 16)
One patient was deceased prior to EEG. Two patients had
normal EEG findings. Fourteen patients had abnormal
readings in the first 24 hours of life; of these, six had mild
EEG abnormalities (score Z 2) and eight had severe
changes (score Z 4). At 72 hours, three of the six patients
with mild EEG abnormalities were unchanged, one patient
progressed to have severe EEG abnormalities (score Z 4),
and two patients had moderate abnormalities (score Z 3;
Tables 2 and 3). We observed a moderate rank correlation
between the EEG and MRI scores at 24 hours (rs Z 0.53,
pZ 0.065) and a statistically significant rank correlation at
72 hours (rs Z 0.67, p Z 0.012).
3.4. Relation between brain MRI and clinical
outcome
Three patients died prior to MRI. Five patients had normal
MRI and normal developmental outcome. Among four
patients with mildly abnormal MRI (score Z 2), one had
normal development at 6 months, two had mild devel-
opmental delay, and one was too young to evaluate.
Three patients with severely abnormal MRI findings
(score Z 3) were deceased. One patient with right pos-
terior cerebral artery (PCA) stroke was excluded from
analysis. There was a statistically significant relationship
between MRI and the clinical outcome (Fisher’s exact
test, p Z 0.0174). MRI obtained at 72 hours of life
demonstrated Positive Predictive Value (PPV); PPV Z 1,
Negative Predictive Value (NPV); NPV Z 0.83, sensitivity
was 100%, and specificity was 83%.
3.5. Twenty-four hours EEG-outcome relation
The relation between EEG recording within the first 24 hours
of life was as follows: two patients with normal EEG had
normal outcome (scoreZ 1); and of two patients with mild
EEG abnormalities (score Z 2), one had speech delay and
one had global developmental delay. Three patients with
moderate EEG abnormalities (score Z 3) had normal
outcome. Among seven patients with severely abnormal EEG
312 T. Nanavati et al(score Z 4), five died, and two had good outcomes. One
patient was too young to evaluate for neurological outcome
(Table 3). EEG at 24 hours demonstrated PPV Z 0.5,
NPVZ 1, sensitivityZ 100%, and specificityZ 50%; EEG at
72 hours demonstrated PPV Z 0.8, NPV Z 0.85,
sensitivity Z 80%, and specificity Z 70% (total of 15 pa-
tients). There was a statistically significant relationship be-
tween EEG severity scale at 24 hours and clinical outcome
(Fisher’s exact test, pZ 0.024), but no significant relation-
ship at 72 hours (Fisher’s exact test, pZ 0.273).
An AIC stepwise multinomial logistic regression was used
to investigate the relationship between the EEG severity
scale at 24 hours, MRI severity scales, and the clinical
outcome. We observed that EEG was not retained in the
final model, thus yielding confirmatory evidence of the MRI-
outcome relationship as previously noted. We used a log-
linear model to further investigate the combined relation-
ship of EEG and MRI with the clinical outcome and found no
evidence to support the combined relationship (likelihood
ratio test p Z 0.349).
3.6. Relation between MRI-plus-EEG at 24 hours or
72 hours of life and clinical outcome
Three patients died prior to testing. Among the remaining
14 patients, two had normal EEG and MRI and normal clin-
ical outcome.
3.7. Severe MRI findings (4 patients)
Three patients had severe EEG abnormalities and are
deceased; one had moderate EEG abnormalities at both
time points and had mild delay.
3.8. Mild MRI findings (5 patients)
Two patients with mild EEG abnormalities at 24 hours and
72 hours had variable outcomes (one was developmentally
appropriate and had speech delay); three patients had
abnormal EEG at 24 hours and 72 hours and had variable
outcome.
3.9. Normal MRI findings (5 patients)
Two patients had normal EEG findings at 24 hours and 72
hours and were clinically intact. EEGs of the remaining
three patients demonstrated abnormalities at 24e72 hours,
but the patients had no developmental problems (Tables 2
and 3).
The EEG severity scale measure was not retained in the
AIC selected model, so there is no evidence that the EEG at
72 hours provided additional information about the
outcome above that which is contained in the MRI. This was
confirmed by the log-linear model results (likelihood ratio
test p Z 0.209).
We additionally considered the effect of the change in EEG
severity scale between 24 hours and 72 hours. Given that the
EEG severity scale is ordinal, we categorized the change be-
tween the 24 hours and 72 hours EEG measurements as an
improvement, no change or a worsening in condition. There
was no statistically significant relationship between achange, in EEG scale of severity, and clinical outcome
(Fisher’s exact test, pZ 0.828). For the multinomial logistic
regression model that included the change in the EEG scale
and the MRI scale, AIC model selection removed the catego-
rized change in EEG reading from themodel and retained only
the MRI scale. This was confirmed by the log-linear model
results (likelihood ratio test pZ 0.589).
For this study, the statistical evidence suggests that EEG
and MRI data contain similar information. The AIC-selected
multivariable multinomial logistic regression model high-
lights the MRI-outcome relationship by selecting out the
EEG information.
3.10. Outcome prediction
Taking a different perspective from the previous analysis,
we explored the ability of EEG and MRI to predict out-
comes. We used random forests and the resulting scree
plots of variable-importance to identify variables that
could play an important role in predicting the develop-
mental outcome status of the children. Identified key
predictors include the EEG readings at 24 hours and 72
hours as well as the MRI assessment for normal readings
(yes/no). Although the ranking of the predictors should not
be heavily interpreted, the MRI scale was a highly ranked
predictor amongst the classification trees in the random
forest.14
Focusing on the important predictors (EEG at 24 hours,
EEG at 72 hours, and MRI findings), random forests yield
evidence of the combined predictive utility of early EEG
and MRI for the clinical outcomes (normal, delayed,
deceased). Although the classification error for the three
groups suggests an overly optimistic estimate of the error
(out of bag errore0.0%), the structure of the trees in the
random forest suggests that prediction using nonpara-
metric classification trees may be a useful approach (me-
dian tree depth -3, minimum tree depth -2, maximum tree
depth -7).
4. Discussion
Despite continued progress in diagnostic modalities, accu-
rate prediction of outcome for neonates with HIE remains a
great challenge, particularly for neonates with mild-to-
moderate injury. This study confirms that MRI can reliably
predict outcome only in severe HIE cases. Early EEG findings
(24 hours) do not provide additional support for outcome
prediction and are nonspecific, possibly in relation to
medication use.15,16
Given its sensitivity in detecting ischemic lesions, MRI is
currently the standard of care imaging modality for diag-
nosis of HIE, although there is an ongoing debate regarding
imaging time, as it is possible to underestimate the severity
of lesions during the first few days of life.17
MRI sensitivity of 91% and specificity of 51% in detecting
HIE, when performed between 1 day and 30 days, has been
reported, but statistical heterogeneity was observed when
the study was subgrouped into early and late MRI, with late
MRI having a higher sensitivity and specificity (99% and 53%,
respectively), when compared to early MRI (sensitivity 85%;
specificity 86%).18 Severe abnormalities on T1 and T2
EEG, MRI, and clinical outcome in neonates with HIE 313weighted images can predict severe disability at 18e24
months of age (PPV Z 0.76 in cooled, and PPV Z 0.74, in
noncooled neonates).19 However, conflicting results have
been reported by a recent study showing a similar adverse
developmental outcome in infants with either normal or
abnormal signal intensity in posterior limb of internal
capsule.18 In 167 term infants with severe HIE, abnormal-
ities in the basal ganglia/thalami had a high predictive
value for death or cerebral palsy (PPVZ 0.88, NPVZ 0.86,
sensitivity Z 0.71, and specificity Z 0.94).20e22 By
contrast, 108 infants with mild-moderate lesions (water-
shed lesions, punctuate white matter lesions, abnormal
signal intensities in the basal ganglia/thalami) did not
develop cerebral palsy.18 Hence, it appears that although
traditional MRI can be an effective biomarker of disease
and treatment efficacy in severe cases, it is not sensitive
and specific for detection of mild-to-moderate lesions.
DWI and ADC, both measures of magnitude of water
diffusion in cerebral tissue, are considered to be the most
sensitive sequences for early detection of ischemic le-
sions.21 Signal abnormalities occur within minutes after
ischemia due to the shift of water from the extracellular to
intracellular space resulting in a slowing of water diffu-
sion. High ADC values indicate disorganization of white
matter tracts, and unfavorable outcome.23 The value of
DWI/ADC changes in neonates is less certain; diffusion
characteristics are different in newborns because of
incomplete myelination, immature blood brain barrier,
and poorly developed autoregulation of cerebral blood
flow. Hence, abnormal ADC valuesdevident in adults 1e7
days after a strokedmay not be apparent in neonates until
later.24e28
In our case series, MRI demonstrated a very high
sensitivity and a good specificity, but the limited number
of patients, and particularly the small number of patients
with mild-to-moderate findings, raises a question about
the significance of this finding for the intermediate group.
In addition, when a different statistical approach was un-
dertaken (random forests model) our data demonstrated a
correlation between MRI findings and clinical outcome,
and they suggested that MRI could be an important pre-
dictor of outcome in relation to absence/presence of
abnormal imaging findings. Accurate prediction of degree
of severity appears less certain, particularly in the mild-
to-moderate group; these patients had either normal
outcome or various degrees of developmental delay, and
similar MRI findings were associated with different
outcome (Figure 1).
The mortality rate in our patients was 23.5%, higher than
the reported 13%.4 This finding is likely to be associated
with the higher percentage of severe HIE (41% vs. 32% on
admission examination) in this cohort, with a higher num-
ber of neonates requiring pressors and AEDs. This severe
cohort might have falsely increased the strength of MRI
findings for prediction of outcome.
Multiple researchers have investigated the utility of
early EEG recordings in predicting outcome in cooled and
noncooled infants with HIE.15,16,19,25 Pressler et al15
demonstrated normal neurological outcome in HIE infants
with moderate EEG abnormalities in the first 8 hours of life
which showed early improvement (12e24 hours). In infants
who continued to have severely abnormal EEG findings,death, spastic quadriplegia, and major developmental
delay were observed.38,39 There have been conflicting re-
ports regarding EEG findings in outcome prediction.15,16
Studies suggest that EEG can be a useful predictor of
outcome in severe HIE injuries, but that it is not a strong
predictor of developmental outcome in mild-to-moderate
cases.34
Researchers have attempted to use amplitude-integrated
EEG (aEEG) to predict outcome in neonates with neuronal
injury, but the results are conflicting36,37 and falsely
abnormal aEEGs have been reported with shivering in the
hypothermic neonate.29,35 Reliable prediction of outcome
(PPV Z 0.92) by abnormal aEEG background was demon-
strated only at 60 hours after HIE, but not at earlier stages.35
Our data demonstrate that early EEG findings may have
utility for predicting clinical outcomes despite the lack of
associative evidence from the multinomial logistic regres-
sion models. Early EEG can be misleading, as some infants
demonstrated severely suppressed EEG in the first 24 hours
but had a later EEG improvement and ultimately did well.
This is supported by the low specificity (50%) of EEG findings
at 24 hours. The early EEG suppression could be related to
medication administration; hence, caution should be used
about utilizing early EEG findings alone to make diagnostic
and/or prognostic decisions.
A combination of different diagnostic modalities (MRI
plus somatosensory evoked potentials,29,30 MR spectros-
copy,32 and aEEG36) to improve prognosis accuracy has been
attempted, but MRI still remains the best modality for
predictor of motor outcome,31,33 as other tests lack sensi-
tivity or/and specificity particularly in the mild-to-
moderate group.26,28,31,34 To our knowledge, only one
study has investigated the predictability of outcome based
on a combination EEG and MRI, reporting a good correlation
between EEG and MRI findings and outcomes in neonates
with severe injury.40
Our statistical model using random forests and scree plots
suggests that the combination of EEG and MRI may have some
role in predicting the clinical outcome. MRI findings are
beneficial when these findings are unambiguous; in this
instance, MRI continues to be crucial as a predictor of clinical
outcome. A larger study could support the development of a
model to better explore the predictive power of EEG; in our
study EEG findings provided no additional associative infor-
mation regarding developmental outcome. It is possible that
in mild-to-moderate HIE cases, MRI and EEG, even when used
in combination, may not be sufficient to predict degrees of
severity accurately. Therefore, we advocate the need for the
development of precise, quantitative tools for more rigorous
evaluation and accurate prognosis of HIE. Recent studies have
suggested that use of advanced MRI modalities (diffusion
tensor imaging; fractional anisotropy) that allow for quanti-
fication of white matter damage and investigation of tissue
architectureandorganization33mayhelpdefine thepattern of
lesions characteristic of mild-to-moderate brain injury and
possibly allow for accurate prediction of clinical outcome.5. Conclusion
Accurate prediction of neurodevelopmental outcome in
neonates with HIE remains difficult, particularly for mild-
Figure 1 Magnetic resonance imaging (MRI) images in three patients showing similar findings despite different clinical outcomes.
(A) Patient 1: Restricted diffusion in parietal/occipital/temporal white matter and thalami on day of life (DOL) 4. The patient had
normal neurological outcome at 4 months; (B) Patient 12: Restricted diffusion in bilateral thalami on DOL 5. The patient is
deceased; (C) Patient 11: Restricted diffusion in bilateral thalami, corona radiata and parietal/occipital cortex. At 36 months the
patient had mild developmental and speech delay.
314 T. Nanavati et alto-moderate cases. MRI appears to be the most reliable tool
for severe cases. Caution should be used when discussing
prognosis for neonates with mild-to-moderate HIE based on
early MR imaging and EEG findings.
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Appendix 1
Cooling protocol: Clinical findings include a cord pH or blood
gas at <1 hour of age, with a pH < 7.0 or base deficit
>16 mEq/L. If a blood gas is not available or pH is between
7.01 and 7.15 or base deficit of 10e15.9, the infant should
have had an acute perinatal event and either an APGAR score
<5 at 10 minutes or continued need for assisted ventilation
for >10 minutes. If these criteria are met, neurological ex-
amination is performed by two independent neonatologists or
a pediatric neurologist is obtained, to define moderate and
severe encephalopathy according to seizures or presence of
one or more signs in three of the six categories as follows:
Moderate
encephalopathy
Severe
encephalopathy
Level of
consciousness
Lethargic Stupor/coma
Spontaneous
activity
Decreased activity No activity
Posture Distal flexion
Full extension
Decerebrate
Tone Hypotonia
Focal, general
Flaccid
Primitive
reflexes
Weak suck
Incomplete moro
Absent suck
Absent moro
Autonomic
system
Constricted pupils
Bradycardia
Periodic breathing
Skew deviation,
dilated, nonreactive
to light pupils
Variable heart rate
Apnea
316 T. Nanavati et alTherapeutic hypothermia is initiated in eligible infants
as soon as possible within 6 hours of birth to achieve and
maintain an esophageal temperature of 33.5C for a periodof 72 hours, followed by gradual rewarming by increasing
the core body temperature at the rate of 0.5C/h over a
period of 6 hours.
The Food and Drug Administrationeapproved Blanketrol
II Hyper/Hypothermia System, (manufactured by Cincinnati
Sub-Zero, Cincinnati, OH, USA), was the hypothermia de-
vice for thermoregulation. The infant is placed on a cooling
blanket in an open warmer with no layers of clothing be-
tween the infant and the cooling blanket. The cooling
blanket should lie flat, with no kinks in the connecting
hoses. The infant should lay supine on the blanket. An
esophageal probe will then be used to measure the set
point esophageal temperature which should be at 33.5C.
Fluctuations in this temperature are to be expected, but
should not be greater than 1C from the set point. Once the
set point is reached, a thin layer (such as a receiving
blanket) may be placed on the infant. Temperatures from
the esophageal probe, infant’s skin and the cooling blanket
will be monitored every 15 minutes for the first 4 hours of
therapy. Temperatures will then be recorded hourly until 12
hours of cooling and then every 2 hours until the 72 hours of
cooling therapy has been completed. Upon completion of
72 the hour cooling period, the infant will be rewarmed
gradually so that the core body temperature will increase
0.5C each hour over a 6 hour period.
